Drug details
Jentadueto (linagliptin and metformin hydrochloride)
type of Antidiabetics, Biguanides/Dipeptyl Peptidase-IV Inhibitors
Jentadueto (linagliptin and metformin hydrochloride) is a combination of two 2 oral antihyperglycemic drugs indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- loss of appetite,
- itching,
- vomiting,
- fever,
- lightheadedness,
- shortness of breath,
- fast heartbeats,
- tiredness,
- stomach pain,
- dizziness,
- weakness,
- sore throat,
- burning eyes,
- skin pain,
- red or purple skin rash with blistering and peeling,
- feeling cold,
- severe pain in your upper stomach spreading to your back,
- blisters,
- rapid weight gain
- unusual muscle pain,
- slow or irregular heart rate,
- swelling in your legs or feet, and
- breakdown of the outer layer of skin,
- severe or ongoing pain in your joints,
The following drugs are related to Jentadueto, either as a replacement or used together:
- Amaryl Tablets (glimepiride)
- Avapro (irbesartan)
- Byetta (exenatide injection)
- Capoten (captopril)
- Diabinese (chlorpropamide)
- Zegalogue (dasiglucagon injection)
- Monopril (fosinopril sodium)
- Monopril HCT (fosinopril sodium-hydrochlorothiazide tablets)
- Glucotrol XL (glipizide extended release)
- NovoLog (insulin aspart [rdna origin] inj)
- NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart (rdna origin))
- Lyumjev (insulin lispro-aabc injection)
- Victoza (liraglutide [rdna] injection)
- NovoLog Mix 50/50 (50% insulin aspart protamine suspension and 50% insulin aspart injection)